Frontlight ResearchEarly access
Trial site
University of California San Francisco-Fresno
- 5running trials
- 4closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Fatty liver disease (MASLD/MASH)2 trials
- High blood pressure2 trials
- Liver cirrhosis2 trials
- Pulmonary arterial hypertension2 trials
- Aortic aneurysm1 trial
- Bronchiectasis1 trial
- Deep vein thrombosis and pulmonary embolism1 trial
- Hodgkin lymphoma1 trial
- Spinal cord injury1 trial
- Phase
- Phase 23 trials
- Phase 32 trials
- Phase 41 trial
- Status
- Active, not recruiting3 trials
- Completed2 trials
- Terminated2 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Bolton Medical1 trial
- Gilead Sciences1 trial
- Intercept Pharmaceuticals1 trial
- Madrigal Pharmaceuticals, Inc.1 trial
- Mannkind Corporation1 trial
- and 4 more
Running trials
Recruiting
ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
Active, not recruiting
Active, not recruiting
Active, not recruiting
Post-Approval Study of the TREO Abdominal Stent-Graft System
Enrolling by invitation
Transforming Research and Clinical Knowledge in Spinal Cord Injury
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Hodgkin lymphoma1 recruiting
- Spinal cord injury1 recruiting
Closed trials
Terminated
Terminated
FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) Study
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026